CHARACTERIZATION OF CEFTRIAXONE-RESISTANT ENTEROBACTERIACEAE - A MULTICENTER STUDY IN 26 FRENCH HOSPITALS

被引:51
作者
GOLDSTEIN, FW
PEAN, Y
ROSATO, A
GERTNER, J
GUTMANN, L
机构
[1] UNIV PARIS,HOP INT,BACTERIOL LAB,F-75014 PARIS,FRANCE
[2] HOP BROUSSAIS,MICROBIOL MED LAB,F-75674 PARIS 14,FRANCE
关键词
D O I
10.1093/jac/32.4.595
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
During a multicentre study performed in 26 French hospitals, 287 (3·2%) of 9038 Enterobacteriaceac isolated, mainly Enterobacter spp., Serratia spp., Citrobacter spp. and Kiebsiella spp. were classified as ceftriaxone resistant on the basis of an MIC >4 mg/L or the presence of an extended-spectrum β-lactamase. Extended-spectrum β-lactamase was present mainly in Kiebsiella pneumoniae (65 strains, 10·2%) and very rarely in Escherichia coli, Proteus mirabilis, Klebsiella oxytoca, Citrobacter spp. and Enterobacter spp. The extended-spectrum β-lacta mases conferred low-level resistance to ceftriaxone in nearly 60% of the strains harbouring them, emphasizing the need for routine testing for the presence of these enzymes. Among transconjugants three types of extended-spectrum β-lactamase were identified. Those resembling TEM-3 were the most common, but TEM-21, and SHV-4 were also found. Clavulanate and to a lesser extent sulbactam inhibited all the extended-spectrum β-lactamases encountered in this study. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:595 / 603
页数:9
相关论文
共 17 条
  • [1] ACAR J, 1991, PATHOL BIOL PARIS, V39, P737
  • [2] OUTBREAK OF NOSOCOMIAL INFECTIONS DUE TO KLEBSIELLA-PNEUMONIAE PRODUCING SHV-4 BETA-LACTAMASE
    ARLET, G
    SANSONLEPORS, MJ
    ROUVEAU, M
    FOURNIER, G
    MARIE, O
    SCHLEMMER, B
    PHILIPPON, A
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (11) : 797 - 803
  • [3] BRUNBUISSON C, 1987, LANCET, V2, P302
  • [4] SHV-5, A NOVEL SHV-TYPE BETA-LACTAMASE THAT HYDROLYZES BROAD-SPECTRUM CEPHALOSPORINS AND MONOBACTAMS
    GUTMANN, L
    FERRE, B
    GOLDSTEIN, FW
    PINTOSCHUSTER, E
    ACAR, JF
    COLLATZ, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) : 951 - 956
  • [5] MORE EXTENDED-SPECTRUM BETA-LACTAMASES
    JACOBY, GA
    MEDEIROS, AA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) : 1697 - 1704
  • [6] JARLIER V, 1988, REV INFECT DIS, V10, P867
  • [7] DISSEMINATION OF THE NOVEL PLASMID-MEDIATED BETA-LACTAMASE CTX-1, WHICH CONFERS RESISTANCE TO BROAD-SPECTRUM CEPHALOSPORINS, AND ITS INHIBITION BY BETA-LACTAMASE INHIBITORS
    KITZIS, MD
    BILLOTKLEIN, D
    GOLDSTEIN, FW
    WILLIAMSON, R
    NHIEU, GTV
    CARLET, J
    ACAR, JF
    GUTMANN, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (01) : 9 - 14
  • [8] EVOLUTION OF PLASMID-CODED RESISTANCE TO BROAD-SPECTRUM CEPHALOSPORINS
    KLIEBE, C
    NIES, BA
    MEYER, JF
    TOLXDORFFNEUTZLING, RM
    WIEDEMANN, B
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) : 302 - 307
  • [9] TRANSFERABLE RESISTANCE TO CEFOTAXIME, CEFOXITIN, CEFAMANDOLE AND CEFUROXIME IN CLINICAL ISOLATES OF KLEBSIELLA-PNEUMONIAE AND SERRATIA-MARCESCENS
    KNOTHE, H
    SHAH, P
    KRCMERY, V
    ANTAL, M
    MITSUHASHI, S
    [J]. INFECTION, 1983, 11 (06) : 315 - 317
  • [10] DETECTION OF EXTENDED BROAD-SPECTRUM BETA-LACTAMASES IN ENTEROBACTERIACEAE IN 4 FRENCH HOSPITALS
    LEGRAND, P
    FOURNIER, G
    BURE, A
    JARLIER, V
    NICOLAS, MH
    DECRE, D
    DUVAL, J
    PHILIPPON, A
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (06) : 527 - 529